These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 27594347)
21. Lesional skin in vitiligo exhibits delayed in vivo reepithelialization compared to the nonlesional skin. Gupta A; Chauhan A; Priya A; Mantri B; Wadhokar M; Dalave K; Shah B; Gokhale RS; Batra VV; Singh A Wound Repair Regen; 2020 May; 28(3):307-314. PubMed ID: 32003499 [TBL] [Abstract][Full Text] [Related]
22. Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo. Gauthier Y; Cario-Andre M; Lepreux S; Pain C; Taïeb A Br J Dermatol; 2003 Jan; 148(1):95-101. PubMed ID: 12534601 [TBL] [Abstract][Full Text] [Related]
23. Epidermal reconstructs in vitiligo: an extrinsic factor is needed to trigger the disease. Bessou S; Gauthier Y; Surlève-Bazeille JE; Pain C; Taïeb A Br J Dermatol; 1997 Dec; 137(6):890-7. PubMed ID: 9470904 [TBL] [Abstract][Full Text] [Related]
24. Autologous noncultured, nontrypsinized melanocyte-keratinocyte graft homogenized in plasma gel followed by narrow-band ultraviolet B therapy for stable vitiligo: A novel technique. Elgarhy LH; Nofal OE; El-Shorbagy SH; Abdel-Latif AM Dermatol Ther; 2020 Nov; 33(6):e14362. PubMed ID: 33006221 [TBL] [Abstract][Full Text] [Related]
25. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis. Moretti S; Fabbri P; Baroni G; Berti S; Bani D; Berti E; Nassini R; Lotti T; Massi D Histol Histopathol; 2009 Jul; 24(7):849-57. PubMed ID: 19475531 [TBL] [Abstract][Full Text] [Related]
26. Narrow-band UVB effects on cutaneous vitamin D receptor expression and serum 25-hydroxyvitamin D in generalized vitiligo. El-Hanbuli HM; Dawoud NM; Mahmoud RH Photodermatol Photoimmunol Photomed; 2018 May; 34(3):175-183. PubMed ID: 29080365 [TBL] [Abstract][Full Text] [Related]
27. Three-dimensional structure analysis of melanocytes and keratinocytes in senile lentigo. Mizutani Y; Yamashita M; Hashimoto R; Atsugi T; Ryu A; Hayashi A; Rikimaru-Nishi Y; Ohta K Microscopy (Oxf); 2021 Mar; 70(2):224-231. PubMed ID: 32991711 [TBL] [Abstract][Full Text] [Related]
28. Ultrastructural study of vitiligo. Galadari E; Mehregan AH; Hashimoto K Int J Dermatol; 1993 Apr; 32(4):269-71. PubMed ID: 8486458 [TBL] [Abstract][Full Text] [Related]
29. Histopathologic features in vitiligo. Kim YC; Kim YJ; Kang HY; Sohn S; Lee ES Am J Dermatopathol; 2008 Apr; 30(2):112-6. PubMed ID: 18360112 [TBL] [Abstract][Full Text] [Related]
30. Repigmentation patterns induced by NB-UVB and their relationship with melanocytic migration and proliferation in vitiligo. Castanedo-Cázares JP; Cortés-García JD; Fuentes-Ahumada C; Martinez-Rosales K; Torres-Álvarez B Photodermatol Photoimmunol Photomed; 2016 Sep; 32(5-6):269-275. PubMed ID: 27627998 [TBL] [Abstract][Full Text] [Related]
31. Perilesional vs. lesional skin changes in senile lentigo. Cario-Andre M; Lepreux S; Pain C; Nizard C; Noblesse E; Taïeb A J Cutan Pathol; 2004 Jul; 31(6):441-7. PubMed ID: 15186432 [TBL] [Abstract][Full Text] [Related]
32. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Le Poole IC; van den Wijngaard RM; Westerhof W; Das PK Am J Pathol; 1996 Apr; 148(4):1219-28. PubMed ID: 8644862 [TBL] [Abstract][Full Text] [Related]
33. [Quantitative ultrastructural study of the epidermis basal layer in the vitiligo patches and in the marginal hyperchromic and normal skin (author's transl)]. Gonçalves RP; Bechelli LM; Trad ES; Zanin LC Ann Dermatol Venereol; 1978 Apr; 105(4):395-400. PubMed ID: 686613 [TBL] [Abstract][Full Text] [Related]
34. [Studies on the follicular melanocytes in the repigmented area of vitiligo after PUVA treatment (author's transl)]. Fukuda S Nihon Hifuka Gakkai Zasshi; 1979 Apr; 89(5):355-67. PubMed ID: 313465 [No Abstract] [Full Text] [Related]
35. Vitiligo non-responding lesions to narrow band UVB have intriguing cellular and molecular abnormalities that may prevent epidermal repigmentation. Goldstein NB; Steel A; Tomb L; Berk Z; Hu J; Balaya V; Hoaglin L; Ganuthula K; Patel M; Mbika E; Robinson WA; Roop DR; Norris DA; Birlea SA Pigment Cell Melanoma Res; 2024 May; 37(3):378-390. PubMed ID: 38343115 [TBL] [Abstract][Full Text] [Related]
36. Melanocytes and keratinocytes morphological changes in vitiligo patients. A histological, immunohistochemical and ultrastructural analysis. Elsherif R; Mahmoud WA; Mohamed RR Ultrastruct Pathol; 2022 Mar; 46(2):217-235. PubMed ID: 35243959 [TBL] [Abstract][Full Text] [Related]
37. Ultrastructural studies in stable vitiligo. Panuncio AL; Vignale R Am J Dermatopathol; 2003 Feb; 25(1):16-20. PubMed ID: 12544094 [TBL] [Abstract][Full Text] [Related]
38. Immunolocalization of tenascin-C in vitiligo. Abdou AG; Maraee AH; Shoeib MA; Elbana R Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383 [TBL] [Abstract][Full Text] [Related]
39. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients. Linthorst Homan MW; Spuls PI; Nieuweboer-Krobotova L; de Korte J; Sprangers MA; Bos JD; Wolkerstorfer A; van der Veen JP J Eur Acad Dermatol Venereol; 2012 Jun; 26(6):690-5. PubMed ID: 21711467 [TBL] [Abstract][Full Text] [Related]